These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953 [TBL] [Abstract][Full Text] [Related]
5. Hoarding in obsessive-compulsive disorder and related disorders: a preliminary report of 15 cases. Seedat S; Stein DJ Psychiatry Clin Neurosci; 2002 Feb; 56(1):17-23. PubMed ID: 11929567 [TBL] [Abstract][Full Text] [Related]
6. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment. Saxena S; Maidment KM; Vapnik T; Golden G; Rishwain T; Rosen RM; Tarlow G; Bystritsky A J Clin Psychiatry; 2002 Jan; 63(1):21-7. PubMed ID: 11838621 [TBL] [Abstract][Full Text] [Related]
7. Pathological hoarding. Jefferys D; Moore KA Aust Fam Physician; 2008 Apr; 37(4):237-41. PubMed ID: 18398520 [TBL] [Abstract][Full Text] [Related]
8. Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up. van Oppen P; van Balkom AJ; de Haan E; van Dyck R J Clin Psychiatry; 2005 Nov; 66(11):1415-22. PubMed ID: 16420079 [TBL] [Abstract][Full Text] [Related]
9. The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder. Williams MT; Farris SG; Turkheimer EN; Franklin ME; Simpson HB; Liebowitz M; Foa EB J Anxiety Disord; 2014 Aug; 28(6):553-8. PubMed ID: 24983796 [TBL] [Abstract][Full Text] [Related]
10. Escitalopram in obsessive-compulsive disorder: response of symptom dimensions to pharmacotherapy. Stein DJ; Carey PD; Lochner C; Seedat S; Fineberg N; Andersen EW CNS Spectr; 2008 Jun; 13(6):492-8. PubMed ID: 18567973 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study. Mundo E; Bianchi L; Bellodi L J Clin Psychopharmacol; 1997 Aug; 17(4):267-71. PubMed ID: 9241005 [TBL] [Abstract][Full Text] [Related]
13. Clinically significant hoarding in obsessive-compulsive disorder: results from an Indian study. Chakraborty V; Cherian AV; Math SB; Venkatasubramanian G; Thennarasu K; Mataix-Cols D; Reddy YC Compr Psychiatry; 2012 Nov; 53(8):1153-60. PubMed ID: 22796017 [TBL] [Abstract][Full Text] [Related]
14. Neurobiology and treatment of compulsive hoarding. Saxena S CNS Spectr; 2008 Sep; 13(9 Suppl 14):29-36. PubMed ID: 18849909 [TBL] [Abstract][Full Text] [Related]
15. Hoarding in children and adolescents with obsessive-compulsive disorder: prevalence, clinical correlates, and cognitive behavioral therapy outcome. Højgaard DRMA; Skarphedinsson G; Ivarsson T; Weidle B; Nissen JB; Hybel KA; Torp NC; Melin K; Thomsen PH Eur Child Adolesc Psychiatry; 2019 Aug; 28(8):1097-1106. PubMed ID: 30656432 [TBL] [Abstract][Full Text] [Related]
16. Compulsive hoarders: how do they differ from individuals with obsessive compulsive disorder? Neziroglu F; Weissman S; Allen J; McKay D Psychiatry Res; 2012 Nov; 200(1):35-40. PubMed ID: 22748189 [TBL] [Abstract][Full Text] [Related]